(Q33336807)

25 July 2017

title

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer (English)

1 reference

25 July 2017

main subject

phase II clinical trial

0 references

0 references

1 reference

M Penz

1

1 reference

25 July 2017

G V Kornek

2

1 reference

25 July 2017

M Raderer

3

1 reference

25 July 2017

H Ulrich-Pur

4

1 reference

25 July 2017

W Fiebiger

5

1 reference

25 July 2017

A Lenauer

6

1 reference

25 July 2017

D Depisch

7

1 reference

25 July 2017

G Krauss

8

1 reference

25 July 2017

B Schneeweiss

9

1 reference

25 July 2017

W Scheithauer

10

1 reference

25 July 2017

publication date

1 February 2001

1 reference

25 July 2017

1 reference

25 July 2017

volume

12

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

183-186

1 reference

25 July 2017

cites work

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. San Antonio Drug Development Team

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008352123009

7 January 2021

Identifiers

DOI

10.1023/A:1008352123009

1 reference

25 July 2017

1 reference